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Summary 22 
How do the key features of protein folding, elucidated from studies on native, isolated 23 
proteins, manifest in cotranslational folding on the ribosome? Using a well-24 
characterized family of homologous α-helical proteins, with a range of biophysical 25 
properties, we show that spectrin domains can fold vectorially on the ribosome and 26 
may do so via a pathway different from that of the isolated domain. We use cryo-27 
electron microscopy to reveal a folded or partially folded structure, formed in the 28 
vestibule of the ribosome. Our results reveal that it is not possible to predict which 29 
domains will fold within the ribosome from analysis of the folding behaviour of 30 
isolated domains; instead we propose that a complex balance between the rate of 31 
folding, the rate of translation and the lifetime of folded or partly folded states will 32 
determine whether folding occurs cotranslationally on actively translating ribosomes.33 
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Our knowledge about protein folding, misfolding and aggregation stems mainly from 34 
in vitro investigations of small, soluble, isolated protein domains that fold reversibly1. 35 
Combined with simulations and theory, such studies have explained how proteins can 36 
fold on a biological timescale and have led to many recent successes in protein   37 
engineering and de novo protein design2-4.  Nonetheless, there is some question as to 38 
whether the key features of protein folding observed for isolated, native domains are 39 
relevant in the context of cotranslational folding on the ribosome and in vivo5. 40 
The vectorial nature of protein synthesis means that N-terminal regions of the 41 
protein are potentially able to fold before C-terminal regions have emerged from the 42 
ribosome6-8. It is estimated that 30 – 40 residues of the nascent chain are sequestered 43 
within the ribosome during translation in a “tunnel” that extends some 100 Å from the 44 
peptidyl transfer center (PTC)9,10; helix formation has been observed in the lower 45 
ribosome tunnel11 (~50-80Å from the PTC) where very small proteins can even 46 
achieve their final folded structure12. Tertiary interactions have been observed to form 47 
within the last 20 Å, in an area of the exit tunnel referred to as the “vestibule”13-15. In 48 
a recent study a poorly characterized compact state was shown to form transiently in 49 
the E. coli HemK protein, when parts of the nascent protein were still enclosed in the 50 
exit tunnel16. Molecular dynamics simulations suggest that sequential folding is 51 
promoted by the ribosome17. Thus, it is still an open question as to whether 52 
cotranslational folding pathways are the same as those observed for isolated, native 53 
proteins, where the entire unfolded protein chain is synchronously transferred into 54 
folding conditions.   55 
Here we investigate the influence of protein stability, folding kinetics and 56 
pathway on cotranslational folding, using an in vitro arrest peptide-based force 57 
measurement assay on a family of all α-helical spectrin domains. Our results suggest 58 
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that for this group of spectrin domains, the ability to fold cotranslationally is not 59 
determined directly by the intrinsic stability, folding rate or pathway of the isolated, 60 
native protein.  Instead we propose that it is the relative stability of folded or partly 61 
folded structures, which can form when a proportion of C-terminal residues are still 62 
sequestered by the ribosome, that determines when folding can occur 63 
cotranslationally.  We also observe for these spectrin domains, that the pathway of 64 
folding on stalled ribosomes may be different from that observed for the native, 65 
isolated protein.  Data provided by cryo-EM shows a partially or fully folded 66 
structured state, formed in the vestibule of the ribosome and we suggest that the 67 
stability of the structured state may be enhanced by interactions with the ribosome.   68 
We discuss these results in the context of cotranslational folding in vivo. We 69 
note that, although these proteins can start to fold before the domain is fully emerged 70 
from the ribosome, it is not possible to predict which domains will fold within the 71 
ribosome from analysis of the folding behavior of the isolated, native proteins.  72 
 73 
Results 74 
Experimental Set-up. We employed six homologous 3-helix bundle spectrin domains 75 
(R15, R16, β16 and three variants of R16) as model proteins (Fig. 1) in our in vitro 76 
arrest peptide-based force measurement assay (AP assay). Such assays have been 77 
recently developed to study the forces generated on the nascent polypeptide chain 78 
during cotranslational membrane protein insertion and protein folding15,18-22.  79 
Translational arrest peptides (APs) induce translational stalling when synthesized on a 80 
ribosome23-26.  Mechanical pulling forces acting on the nascent chain can weaken or 81 
even abolish stalling20,27. When translation is deliberately stalled by a bacterial SecM 82 
 5
AP, the stall can be released by the application of moderate force (around 10 pN) to 83 
the nascent chain21; the probability of release, and hence the yield of full-length 84 
versus stalled protein, is proportional to the force applied. The fraction of released, 85 
full-length protein observed, fFL, can therefore serve as a proxy for the force acting on 86 
the nascent chain20. By measuring fFL as a function of the linker length (L) between 87 
the protein and the arrest site, it is possible to generate a profile that represents the 88 
force generated by the protein as it folds, as a function of the location of the protein in 89 
the ribosome tunnel (for more details see Fig. 2, Supplementary Fig. S1). Each data 90 
point on the force profiles is a single experiment. We know from previous studies that 91 
the SDs for fFL values obtained by translation of arrest-peptide constructs in the PURE 92 
system is on the order of 0.0312. Here we show that replicate measurements of the 93 
same construct produce reproducible data (see Supplementary Fig. S2). 94 
demonstrating the robustness of the assay. The spectrin domains employed in the AP 95 
assay have a range of intrinsic stabilities, rates of folding and unfolding and different 96 
folding pathways, as determined from experiments on the isolated, native domains 97 
(Table 1). (Note that we define intrinsic as relating to the properties of the native 98 
domains in isolation).  We relate the force profiles obtained by the AP assay to these 99 
differences. 100 
 101 
The linker length at which folding can occur does not correlate with the stability or 102 
folding kinetics of the isolated native protein. To determine whether the linker length 103 
at which folding can occur is related to intrinsic thermodynamic stability or folding 104 
rate constant of the isolated domains, force profiles were obtained for spectrins R15, 105 
R16 and β16 by in vitro translation in the PURE system28 (Fig. 3a). Importantly, non-106 
folding variants of R15 and R16 (R15nf, R16nf) did not release translational arrest, 107 
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demonstrating that the force generated is due to cotranslational folding and not to 108 
interactions of the unfolded nascent chain with the ribosome. Both β16 and R16 start 109 
to fold at L = 27-29 residues, i.e., while a part of the nascent chain is still sequestered 110 
in the ribosome, despite possessing quite different intrinsic thermodynamic stabilities 111 
(Table 1). R15 starts to fold only at L = 37 residues, although it has the same intrinsic 112 
stability and folds significantly faster than R16 (Table 1). Thus there is no apparent 113 
correlation between either intrinsic stability of the isolated domains nor rate of 114 
folding, and the linker length at which folding occurs on the ribosome. 115 
 116 
A stabilizing neighbor results in early folding. Spectrin R16 begins to exert a force at 117 
L ≈ 29 residues (Fig. 3a). At this linker length some C-terminal residues will be 118 
sequestered in the ribosome and thus unavailable to form structure. Is it possible that 119 
R16 can fold into a more stable state than R15, when an equivalent number of 120 
residues are in the ribosome exit tunnel, and that this allows R16 to start folding 121 
earlier than R15? To gain an insight into the effect upon protein stability of 122 
sequestration of C-terminal residues in the ribosome, equilibrium denaturation studies 123 
were performed on isolated, native domains R15 and R16 truncated at the C-terminus 124 
(Supplementary Table S1). Our results show R15 is destabilized earlier and to a 125 
greater extent by C-terminal truncation than is R16. Perhaps the stability of structures 126 
that can form, in the absence of some C-terminal interactions, is the key to explaining 127 
the differences between the spectrin domain force profiles? If this were the case, then 128 
stabilization of R16 should cause it to fold at even shorter linker lengths. We have 129 
previously shown that R16 is stabilized by ~1.7 kcal mol-1 by the presence of an N-130 
terminal, folded R15 domain, in the tandem protein R15R1629,30. We therefore 131 
recorded a force profile for R15R16. The results show that in the tandem protein, R16 132 
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starts to fold at significantly shorter linker lengths than does R16 alone (Fig. 3b); we 133 
ascribe this to the extra stability provided by the N-terminal R15 domain. When the 134 
cooperativity between R15 and R16 in the tandem protein is removed by the 135 
introduction of 3 proline residues at the domain boundary31, the force profile of the 136 
resulting R153ProR16 construct reverts to that of R16 alone.   137 
 138 
Simple sequence changes can affect when the protein folds. We recorded force 139 
profiles for two variants of R16, originally designed to incorporate the fast-folding 140 
nucleus of R15 into R1632.  These both have five residues from the A helix of R15 141 
substituted into R16 to generate the R16m5 variant (Fig. 1, bottom); an additional, 142 
conservative substitution in the B helix (V65L) confers an extra ~1 kcal mol-1 of 143 
stability, to generate the protein R16m6 (Fig. 1, bottom). Folding studies have 144 
previously shown that introduction of these five nucleating residues causes both R16 145 
variants to fold more like R15 in terms of rapid kinetics and pathway (Table 1)32. We 146 
find that the force profile of R16m5 does indeed follow that of R15, but stabilization 147 
by just ~1 kcal mol-1  switches the force profile so that R16m6 now resembles that of 148 
R16 (Fig. 3c). Remarkably, the addition of the stabilizing N-terminal R15 domain to 149 
R16m5 also leads to an R15R16-like force profile in the tandem R15R16m5 (Fig. 150 
3b). We also investigated another spectrin variant named R16outside15core 151 
(R16o15c), which contains the entire hydrophobic core of R15 and shares only 152 
surface residues with R16. As an isolated domain this variant has the same intrinsic 153 
rapid folding kinetics and folding pathway as R1533 (Table 1), yet it behaves 154 
indistinguishably from R16 in our AP assay (Fig. 3d).   155 
 156 
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Cryo-EM reveals spectrin R16 is folded in the ribosome vestibule. To ascertain the 157 
location of structured states of R16 in the ribosome tunnel, cryo-EM studies were 158 
performed on the ribosome-bound R16 [L=33] construct, with the SecM AP replaced 159 
by the TnaC AP, a stronger stall sequence that retains the nascent chain bound to the 160 
ribosome. A ~4 - 8 Å resolution structure was determined from arrested ribosome-161 
nascent chain complexes purified from E. coli.  In addition to density corresponding 162 
to parts of the AP and linker segment of the nascent chain in the ribosome tunnel, a 163 
globular density protruding from the tunnel exit was apparent (Fig. 4, 164 
Supplementary Video and Supplementary Fig. S3).  The core of the R16 solution 165 
NMR structure (PDB: 1AJ3) fits into this density, as does most of helix C, while the 166 
regions of helices A and B closest to the ribosomal protein uL24 (C-terminal region of 167 
helix A, N-terminal region of helix B and the A-B loop) are not visible. 168 
 169 
Discussion 170 
Using a combination of the AP-based force-measurement assay and structural analysis 171 
by cryo-EM on a family of all α-helical spectrin domains, we have shown that 172 
spectrin domains can fold cotranslationally, while a proportion of C-terminal residues 173 
remain sequestered by the ribosome; cryo-EM data on the stalled R16 [L=33] shows 174 
spectrin at least partly folded in the vestibule of the ribosome tunnel.  175 
The stability of structures that can form before the protein has entirely emerged is key 176 
to determining when the protein can fold on the ribosome. We find that the point at 177 
which spectrin domains can fold does not correlate with the intrinsic stability, folding 178 
rate or pathway of the isolated, native proteins. This is reflected in the early-onset 179 
force peaks of β16, R16, R16m6 and R16o15c, all of which can fold (and thus exert a 180 
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force to release the stall) before the C-terminal residues are fully emerged from the 181 
tunnel and thus available to participate in structure formation (L < 30 residues). Yet 182 
these proteins share many of the intrinsic folding properties of R15 which folds only 183 
at long linker lengths.  184 
A marginal increase in stability can affect the position of the onset of folding: 185 
A simple V to L substitution allows R16m6 to fold significantly earlier than R16m5, 186 
and addition of the stabilizing R15 domain to R16 or R16m5 allows the protein to 187 
fold even earlier. Thus we propose that the probability that a force sufficient to release 188 
the stall is generated correlates with the stability of folded, or potentially partly-189 
folded, states that form cotranslationally and thus probably with the length of time 190 
these states can persist (if a folded structure that forms cotranslationally lacks 191 
sufficient stability, it will unfold before it has time to release the stall). 192 
 Our results also suggest that the ribosome itself may influence the stability and 193 
lifetime of structured or partly structured species which may form cotranslationally:  194 
R15 can apparently fold only when the protein is almost entirely emerged from the 195 
exit tunnel. A simple explanation is that folded or partly folded structures of R15, 196 
formed within the confines of the ribosome, are not as stable as similar R16 197 
structures. Studies on the isolated proteins show that R15 is more destabilized by 198 
truncation than R16 (Supplementary Table S1), but this difference is not sufficient 199 
to fully explain the ~8-residue difference in the onset of cotranslational folding (Fig. 200 
3a). In the cryo-EM structure, R16 appears to interact with the ribosome (Fig. 4b); we 201 
infer that stabilizing interactions with the ribosome may play a role in determining the 202 
onset of cotranslational folding. Further evidence is provided by R16o15c 203 
(R16outside15core) which folds in isolated protein studies like R15, but follows the 204 
force profile of R16 on the ribosome. It is possible that stabilizing interactions 205 
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between surface residues and the ribosome allow R16o15c to fold cotranslationally 206 
like R16. Interactions with the ribosome have previously been shown to influence the 207 
formation of stable tertiary interactions in the nascent chain34-36. In these cases, 208 
however, folding commenced only when the proteins were well outside the ribosome 209 
exit tunnel and interactions with the ribosome reduced rather than increased the 210 
stability of the folded state. 211 
Relationship between onset of folding and folding pathways. Our previously published 212 
results on folding of the isolated domains of R15 and R1637,38 reveal that the key 213 
interactions that form early when R16 folds are between the N-terminal regions of 214 
helices A and C (regions of structure that can likely form when a significant part of 215 
the C helix is still inside the ribosome tunnel); however in R15 the interactions 216 
essential for folding are between the C-terminal regions of helices A and C (Table 1 217 
and Fig. 1, top).  From the cryo-EM data it is clear that at length L=33, R16 can form 218 
a structured state within the confines of the ribosome. There is a significant region of 219 
structure in the portion of the molecule distal from the tunnel exit. This density can be 220 
fitted using the NMR structure of R16, and is consistent with the packing of the N-221 
terminal portions of all three helices (see Figs 4, 5 and Supplementary Video).  222 
However, in the region closest to the tunnel the observed density is only consistent 223 
with formation of a single helix (assigned to the terminal C helix as it is contiguous 224 
with the nascent chain observed inside the tunnel, colored green in Fig. 4).  Thus, at 225 
this linker length, where the protein is constrained within the vestibule of the 226 
ribosome tunnel, stable tertiary structure is not observed in the C-terminal portion of 227 
the molecule, exactly where we would expect nucleating packing interactions to be 228 
formed in R15 (between the C-terminal regions of helices A and C, shown mapped 229 
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onto the model of the partly folded structure in Fig. 5). This may give an alternative 230 
explanation why R15 can only fold at long linker lengths.  231 
The ribosome can affect the folding pathway. R16m5 can potentially fold via two 232 
alternative pathways: via the ‘R15 pathway’ (by the 5 key residues substituted 233 
towards the C-terminal region) or via the ‘R16 pathway’ (by key residues located 234 
towards the N-terminal region) (Fig. 1, top). In the isolated domain, R16m5 folds via 235 
the C-terminal pathway, which is the lowest energy (faster folding) route.  On the 236 
ribosome R16m5 still behaves like R15, folding only when almost fully emerged from 237 
the ribosome, when the C-terminal folding route becomes available. A single residue 238 
substitution (V65L) generates R16m6, stabilized by an extra ~1 kcal mol-1. Now on 239 
the ribosome R16m6 is observed to fold like R16, commencing folding at shorter 240 
lengths, when the C-terminal pathway is still unavailable. Thus, this extra stabilization 241 
allows the protein to switch folding routes and access the ‘R16 (N-terminal) pathway’ 242 
(Fig. 3c).  Importantly, the mutation that confers the extra stability is in the N-243 
terminal region of the protein that is predicted to be structured in our cryo-EM model 244 
(colored green in Fig. 5).  An even greater stabilizing effect is conferred on R16m5 by 245 
the R15 domain, in the tandem protein R15R16m5, which enables folding to begin at 246 
even shorter linker lengths (Fig. 3b). Thus we infer that if an alternative, sufficiently 247 
low-energy pathway is available, a protein may fold cotranslationally by a different 248 
pathway than that used by the full-length protein (provided that any folded or partly 249 
folded states have sufficient stability). 250 
Implications for cotranslational folding in vivo. Our results provide insights into the 251 
factors affecting when a spectrin domain can fold cotranslationally, in a stalled 252 
ribosome system. Whether or not folding actually occurs within the confines of the 253 
tunnel or vestibule, on actively translating ribosomes, will depend critically upon the 254 
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balance between the rate of folding compared with the rate of translation and also the 255 
lifetime of any structured or partly structured states that form17. Presumably, where 256 
folding is fast compared to the translation rate (~5 codons s-1 in mammalian cells, 257 
~10-20 codons s-1 in E. coli)39,40, there is a significant probability that a folding event 258 
will occur at each step during translation. Whether folding continues to completion at 259 
this chain length will depend on the lifetime of any structured states that are formed. 260 
However, although the folding rates for all these spectrin domains, determined for the 261 
isolated, native proteins, are significantly faster than the rate of translation, it is not 262 
possible to determine the rates of folding (or, indeed unfolding) within the confines of 263 
the ribosome. Since on both stalled and freely translating ribosomes the domains are 264 
folding against the entropic restoring force of the tethered chain, it seems likely that 265 
folding rates are significantly decreased and the probability of unfolding is larger on 266 
the ribosome than off21. Our data suggest, however, that it is indeed possible that R16 267 
can start to fold in the ribosome, and that spectrin domains are apparently able to fold 268 
via a different pathway from that observed in the isolated domain, when confined in 269 
the ribosome.  270 
The relationship between folding of the isolated protein on and off the 271 
ribosome is demonstrably complex: Some small domains, such as R15, will fold only 272 
outside the ribosome exit tunnel, and it is not possible to predict which domains will 273 
fold within the ribosome from analysis of the folding behavior of the isolated, native 274 
proteins. Furthermore, the probability that a protein will fold within the ribosome 275 
tunnel can be altered by seemingly insignificant conservative sequence changes. Early 276 
onset of folding inside the exit tunnel may be particularly important in multidomain 277 
proteins, like spectrin, in order to avoid misfolding by domain swapping41,42; indeed, 278 
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we have seen that stabilizing interactions with a neighboring domain can result in 279 
early onset of cotranslational folding. 280 
  281 
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Figure legends 419 
Figure 1. Three-helix bundle structure of spectrin domains. (Top) Location of key 420 
residues for folding. R16 folds via early formation of stabilizing interactions between 421 
the N-terminal regions helices of A and C (red). R15 folds via interactions between 422 
the C-terminal regions of helices A and C (blue and magenta). (Bottom) Positions of 423 
the five residues from R15 substituted into the A-helix of R16, to form R16m5 424 
(green) and position of the V65L substitution in the B-helix of R16m5, to form 425 
R16m6 (gold). 426 
 427 
Figure 2. Investigating cotranslational folding using an arrest-peptide assay. (a) 428 
(Left) Linker length (L) is short: the domain is unable to fold, translation arrest 429 
persists and no full-length protein is produced. (Right) Design of construct used in the 430 
force profile assays. (b) Intermediate linker length: the domain folds against the 431 
ribosome, translation arrest is released and full-length protein is produced. (c) Linker 432 
length is long: the domain folds away from the ribosome, the arrest persists and no 433 
full-length protein is produced. 434 
 435 
Figure 3. Force Profiles. (a) β16, R15, R16 with non-folding controls. β16 (light 436 
blue), R15 (black), R16 (red). Non-folding (nf) variants of R15 and R16 do not 437 
produce a force. (b) Comparison of R16 with tandem proteins. R16 (red), R15R16 438 
(blue), R153ProR16 (red with dashed line), R15R16m5 (purple with dashed line). (c) 439 
Comparison of R15 and R16 with R16m5 and R16m6. R15 (black), R16 (red), 440 
R16m5 (purple), R16m6 (green). (d) Comparison of R15 and R16 with R16o15c. R15 441 
(black), R16 (red), R16o15c (green). For all plots each point corresponds to a single 442 
measurement. We have shown that measurements are reproducible: data collected 443 
using in vitro translation kits with different lot numbers and from different labs 444 
overlay (see Supplementary Fig. S2). 445 
 446 
Figure 4. Visualization of the R16 spectrin domain at the ribosomal tunnel exit. (a) 447 
Cryo-EM reconstruction of the R16-TnaC [L=33] ribosome-nascent chain complex. 448 
The small ribosomal subunit in yellow, large subunit in grey, the peptidyl-tRNA with 449 
the nascent chain in green and additional density at the ribosomal tunnel exit in red. A 450 
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cross-section through the ribosome shows density for the nascent chain in the 451 
ribosomal tunnel and non-ribosomal density corresponding to the R16 domain (PDB: 452 
1AJ3) at the tunnel exit. (b) Schematic representation of the construct used for cryo-453 
EM is shown on the top. A close-up of the ribosomal tunnel exit shows density for the 454 
R16 domain located between ribosomal helix H59 and ribosomal protein uL24. (c) 455 
Rigid body fit of the NMR structure of the R16 domain colored according to RMSD 456 
(blue: 0.5 to 1.9; white: 2–3.9; red: ≥ 4.0 Å) to the cryo-EM density map at different 457 
contour levels. 458 
 459 
Figure 5. Rigid body fit of the NMR structure of the R16 domain to the cryo-EM 460 
density map showing equivalent locations of R15 key folding residues. Regions that 461 
appear to be structured (for which there is density in the EM) are colored pink, 462 
regions that are apparently unstructured (for which there is no density in the EM) are 463 
colored yellow. The residues in the A-helix important for nucleating folding of R15 464 
are shown in light blue; the V65L substitution in the B-helix is shown in green.  465 
 466 
 467 
 468 
 469 
 470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
 478 
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 480 
Table 1:  Stability and folding rate constants of the spectrin domains used in this study. 481 
 R15 R16 β16 
R16m5 
(A version of R16 with 
5 residues from R15 
substituted in the A 
helix) 
R16m6 
(As R16m5 but with  
an additional 
conservative, stabilizing 
mutation in the B helix)
R16outside15corea 
(R16o15c, a protein with 
all the core residues 
from R15 substituted 
into R16)
Stability 
∆G (kcal mol-1) 
Moderate 
(5.2 ± 0.1) 
Moderate 
(5.0 ± 0.1) 
High 
(9.2 ± 0.2) 
Moderate 
(4.1 ± 0.2) 
Moderate 
(4.8 ± 0.1) 
Moderate 
(5.5 ± 0.2) 
Folding rate 
constant kf  (s-1) 
Very Fast 
(60,000 ± 20,000) 
Slow 
(135 ± 27) 
Fast 
(5200 ± 800b) 
Fast 
(4,300 ± 700) 
Fast 
(13,700 ± 100) 
Fast 
(2200 ± 300) 
Region of the 
protein that folds 
earliest 
C-terminal regions of  
helices A & C 
N-terminal regions of  
helices A & C ND 
C-terminal regions of  
helices A & C 
C-terminal regions of  
helices A & C 
C-terminal regions of  
helices A & C 
 482 
These data are for the 109 amino acid versions of spectrin used in the AP experiments, which are somewhat shorter than those used previously.  Note that this truncation has 483 
lead to a loss of stability of ~ 0.5 - 1 kcal mol-1 but no change in folding rates. Extension of the domains by the linker restores the stability close to that of the original, longer 484 
constructs.  485 
a Stability data for R16o15c are taken from Wensley et al32 for the original construct which has an extra 7 residues at the C-terminus.  486 
b Folding rate constant for β16 is taken from Hill et al43 for the original construct which has an extra 7 residues at the C-terminus.  487 
 488 
 23
Online Methods 489 
Enzymes and chemicals 490 
All enzymes were obtained from Thermo Scientific (Waltham, MA, USA) and New 491 
England Biolabs (Ipswich, MA, USA). Oligonucleotides were purchased from 492 
Eurofins MWG Operon (Ebersberg, Germany). DNA/RNA purification kits were 493 
purchased from Qiagen (Hilden, Germany) and the PUREfrex™ cell-free translation 494 
system was obtained from BioNordika (Stockholm, Sweden).  [35S]-methionine was 495 
purchased from PerkinElmer (Waltham, MA, USA). All other reagents were from 496 
Sigma-Aldrich (St. Louis, MO, USA). 497 
DNA manipulations  498 
All spectrin constructs were synthesized from the previously described pET19b 499 
plasmid (Novagen, Madison, WI, USA) carrying a truncated lepB gene containing a 500 
[6L,13A] H segment insert and the Escherichia coli SecM arrest peptide, 501 
FSTPVWISQAQGIRAGP, under the control of a T7 promoter20. The soluble, non-502 
membrane targeted LepB derivative was generated by a deletion of codons 4-77 using 503 
PCR, corresponding to the removal of transmembrane segments 1 and 2. The resulting 504 
plasmid was digested with SpeI and KpnI to release the [6L, 13A] segment and this 505 
was substituted by segments encoding the 109 residues of spectrin β16, R15, R16, 506 
R16m5, R16m6, R16o15c32,37,43 or the 215 residues of spectrin R15R1630, using the 507 
megaprimer approach44. The spectrin genes were all truncated C-terminally (relative 508 
to previous studies) to end one amino acid after the last conserved leucine residue 509 
(http://pfam.xfam.org/): 5’-WERLR-3’ for β16, 5’-RAKLN-3’ for R15 and 5’-510 
GQRLE-3’ for R16, R16m5, R16m6, R16o15c and R15R16. Starting with the longest 511 
linker, truncations were generated by PCR using partially overlapping 512 
oligonucleotides containing the respective sequence alteration45. By the same 513 
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truncation method, the constructs shown in Fig. 3b (R16, R15R16, R153ProR16, 514 
R15R16m5) were generated with the N-terminal LepB leader segment removed; the 515 
R15R16m5 construct was created by ligating R16m5 in place of R16 using the 516 
megaprimer method. All constructs were verified by DNA sequencing. For each 517 
linker length, L, site-directed mutagenesis was performed to generate constructs with 518 
the non-functional FSTPVWISQAQGIRAGA arrest peptide as full-length controls. 519 
At linker lengths exhibiting substantial force, (L = 37 and 41 residues, Fig. 3a) site-520 
directed mutagenesis was performed to generate non-folding double mutants of R15 521 
(F18D+I55D) and R16 (F11D+L55D)37,38. 522 
In vitro transcription and translation 523 
For the generation of nascent chains, all genes were first PCR-amplified as DNA 524 
constructs containing a 5’ T7 promoter. mRNA transcripts were subsequently 525 
generated by in vitro transcription using T7 RNA polymerase according to the 526 
manufacturer’s instructions (Promega). RNA was purified using the RNeasy Mini Kit 527 
(Qiagen). Translation was performed using the commercially available PUREfrex™ 528 
in vitro system according to the manufacturers’ protocol (New England Biolabs). 529 
Synthesis of [35S]-Met labeled polypeptides was performed at 37 °C, 500 rpm for 530 
exactly 15 minutes. The reaction was quenched by the addition of an equal volume of 531 
10% ice-cold trichloroacetic acid (TCA). The samples were incubated on ice for 30 532 
min and centrifuged for 5 min at 20,800 x g and 4°C. Pellets were dissolved in sample 533 
buffer and treated with RNase A (400 μg ml-1) for 15 min at 37 °C before the samples 534 
were resolved by SDS-PAGE and imaged. Bands were quantified using ImageJ to 535 
obtain an intensity cross section, (http://rsb.info.nih.gov/ij/), which was subsequently 536 
fit to a Gaussian distribution using in-house software. 537 
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 Each data point on the force profiles is a single experiment. The data are 538 
reproducible; data collected using in vitro translation kits with different lot numbers 539 
and from different labs overlay (Supplementary Fig. S2). We also point to the many 540 
different forms of R16 shown in Fig. 3: the profiles for R16 (Fig. 3a), R16 no Lep 541 
leader, R153ProR16 (Fig. 3b), and R16m6 all overlay. 542 
Cloning and purification of R16-TnaC [L=33] ribosome-nascent chain complexes  543 
The construct used for cryo-EM was derived from the spectrin R16 construct used for 544 
in vitro force profile analysis. The SecM stalling sequence was replaced by an 545 
equivalent TnaC46 stalling sequence conserving a linker length of (L=33) to the 546 
spectrin domain. An N-terminal His-tag was introduced for purification. The construct 547 
was subsequently cloned into the pBad vector for in vivo expression of R16-TnaC 548 
RNCs. In vivo expression and purification was carried out as described previously46. 549 
The final spectrin-TnaC sequence used was 550 
HGHHHHHHHHDYDIPTTLEVLFQGPGTKLNESHRLHQFFRDMDDEESWIKEK551 
KLLVSSEDYGRDLTGVQNLRKKHKRLEAELAAHEPAIQGVLDTGKKLSDDN552 
TIGKEEIQQRLAQFVDHWKELKQLAAARGQRLESGSGSGSGGPNILHISVTSK553 
WFNIDNKIVDHRP, including an N-terminal His8-tag for purification and 3C 554 
cleavage site (spectrin R16 sequence underlined). 555 
Cryo-EM specimen preparation, data collection and processing 556 
Freshly prepared spectrin-TnaC RNCs (~ 5 OD260) were applied to 2 nm precoated 557 
Quantifoil R3/3 holey carbon supported grids and vitrified using a Vitrobot Mark IV 558 
(FEI Company). Cryo-EM data was automatically collected on a Titan Krios TEM 559 
(FEI, USA) operated at 300 kV and equipped with a back-thinned Falcon II (FEI, 560 
USA) direct electron detector. Ribosomal particles on the micrographs were detected 561 
using SIGNATURE47. All single-particle processing was performed using the 562 
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SPIDER software package48. The data-set contained a total of 177,543 particles. 563 
Classes were obtained by competitive projection matching48,49, and sorted for t-RNA 564 
presence as well as extra density near the tunnel exit. The final class contained 46,067 565 
particles and the corresponding electron density map showed strong density for t-566 
RNA in the P-Site as well as extra density at the ribosomal tunnel exit. Different 567 
folding intermediates could not be enriched despite different classification attempts. 568 
The final dataset was refined to a final average resolution of 4.8 Å (FSC0.143) (See 569 
Supplementary Fig. S3). To exclude potential overfitting, the data were processed 570 
using a frequency limited refinement protocol by truncating high frequencies (low-571 
pass filter at 8 Å) during the whole refinement process50. For interpretation of the 572 
cryo-EM density, we fitted the structure of the E. coli 70S ribosome (PDB ID: 3OFR), 573 
using UCSF Chimera51.  The fit was assessed by comparing the cross-correlation of 574 
the EM map and the density of the model map. Density not corresponding to proteins 575 
or RNA of the 50S subunit within the ribosomal tunnel was identified as nascent 576 
chain. The non-ribosomal density at the ribosomal tunnel exit was compared with 577 
density maps of the spectrin R16 domain (PDB ID: 1AJ3) at different resolutions and 578 
contour levels. The parts of the spectrin domain having low RMSDs in the NMR 579 
structure show corresponding density in the EM map. Thus, the NMR model of the 580 
spectrin domain was rigid-body fitted according to the highest cross-correlation 581 
between the density model maps and the non-ribosomal electron density.  582 
All figures showing molecular models and electron densities were prepared 583 
with the software UCSF Chimera51. Segmentation of the maps was performed after 584 
docking a ribosomal model into the density and using the command color zone in 585 
Chimera. Some parts of the map are shown at different contour levels. 586 
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Expression and Purification of Isolated Spectrin Domains 587 
This was performed as described previously38. 588 
Measurement of Stability and Kinetics of Isolated Spectrin Domains 589 
Stability and kinetics measurements of the isolated 109 amino acid spectrin domains 590 
and C-terminally truncated variants were performed in 50 mM phosphate buffer (pH 591 
7.0) at 25±°C as described previously38. 592 
 593 
Accession codes. Coordinates for the cryo-EM map of the ribosome with the spectrin 594 
density have been deposited at the Electron Microscopy Data Bank under accession 595 
code EMD 3451. Coordinates of the spectrin model used for fitting and interpretation 596 
of the cryo-EM map have been deposited at the Protein Data Bank under accession 597 
code PDB 5M6S. 598 
Data Availability: The data that support the findings of this study are available 599 
from the corresponding authors upon reasonable request. 600 
  601 
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